
GB HealthWatch
Nutritional genomics platform for chronic disease prevention.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $3.5m Valuation: $26.0m | Series C | |
Total Funding | 000k |
Related Content
GB HealthWatch is a nutritional genomics and digital health company founded in 2012 by Dr. Li Shen, who also serves as the company's President. Headquartered in San Diego, California, the firm operates on a mission to prevent common chronic diseases through targeted, gene-based nutritional and dietary interventions.
The company develops advanced technologies to research the translation of genetic insights into personalized prevention and treatment strategies for complex conditions like coronary heart disease, type 2 diabetes, obesity, and Alzheimer's disease. Its primary offerings include the GBinsight genetic test and the HealthWatch 360 mobile application. GBinsight is a next-generation DNA sequencing (NGS) assay that analyzes the genetic architecture of complex metabolic diseases. The HealthWatch 360 app is an online tool that tracks dietary intake, exercise, and health symptoms to provide users with personalized nutrition plans. The platform also includes a Research Portal, enabling academics, clinicians, and research institutes to manage and analyze data collected via the mobile app.
GB HealthWatch has secured a total of $9.78 million in funding over three rounds, including a Series B round and a pre-Series C round in December 2021 that raised $3.5 million. Investors include Trinity Power, Rotating Boulder Fund, and the U.S. Department of Health and Human Services, which awarded the company a Small Business Innovative Research (SBIR) Grant from the National Institutes of Health (NIH). The funds are aimed at expanding the company's leadership in advanced genetic testing and building out the infrastructure for its preventive health ecosystem.
Keywords: nutritional genomics, personalized nutrition, genetic testing, chronic disease prevention, digital health, precision medicine, HealthWatch 360, GBinsight, cardiometabolic disease, Alzheimer's prevention, diet tracking, gene-based diet, DNA sequencing, health technology, preventative healthcare, metabolic diseases, lifestyle intervention, mobile health app, bioinformatics, research portal